System and methods for performing saliva-based diagnostic screenings
US-2024420847-A1 · Dec 19, 2024 · US
US2022015714A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2022015714-A1 |
| Application number | US-201917297669-A |
| Country | US |
| Kind code | A1 |
| Filing date | Nov 21, 2019 |
| Priority date | Nov 29, 2018 |
| Publication date | Jan 20, 2022 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method for downsampling class-imbalanced sets with survival analysis comprising: acquiring a class-imbalanced data set, wherein the class-imbalanced data set comprises biological data from a plurality of subjects, wherein the biological data of each subject includes an observation, a time value, and a plurality of clinical measurements, and wherein the biological data is categorized as being part of a majority data class or a minority data class, wherein the majority data class has a greater number of observations than the minority data class; downsampling the class-imbalanced data set, wherein the downsampling results in the majority data class having an equivalent or substantially equivalent number of observations as the minority data class; and performing cross-validation on the downsampled data set with a survival analysis to generate a survival model, wherein the observation comprises an event or no event at a specific time value.
Opening claim text (preview).
1 . A method comprising: a) acquiring a class-imbalanced data set, wherein the class-imbalanced data set comprises biological data from a plurality of subjects, wherein the biological data of each subject includes an observation, a time value, and a plurality of clinical measurements, and wherein the biological data is categorized as being part of a majority data class or a minority data class, wherein the majority data class has a greater number of observations than the minority data class; b) downsampling the class-imbalanced data set to generate a downsampled data set, wherein the downsampling results in the majority data class having an equivalent or substantially equivalent number of observations as the minority data class; and c) performing cross-validation on the downsampled data set with a survival analysis to generate a survival model; wherein the observation comprises an event or no event at a specific time value, wherein an AUC, sensitivity, specificity, and/or C-index of the survival model is closer to 1 than a AUC, sensitivity, specificity, and/or C-index of a survival model where the class-imbalanced data set was not downsampled prior to the survival analysis. 2 . (canceled) 3 . The method of claim 1 , wherein the class-imbalanced data set is a survival data set. 4 . The method of claim 1 , wherein the event is a disease, disorder, or condition of a subject. 5 . The method of claim 1 , wherein the survival analysis is selected from the group consisting of a Cox proportional hazard analysis, a random forest analysis, an accelerated failure time analysis, and any combination thereof. 6 . The method of claim 5 , further comprising an elastic net penalty. 7 . The method of claim 1 , wherein the cross-validation is at least a 2-fold, 3-fold, 4-fold, 5-fold, 6-fold, 7-fold, 8-fold, 9-fold, 10-fold, 11-fold, 12-fold, 13-fold, 14-fold, 15-fold, 16-fold, 17-fold, 18-fold, 19-fold, or 20-fold cross-validation. 8 . The method of claim 1 , wherein the survival model comprises from 5 to 1,000 features, wherein each feature is selected from the group consisting of a protein measurement, a clinical factor, and a combination thereof. 9 . The method of claim 8 , wherein the clinical factor is selected from the group consisting of age, weight, blood pressure, height, BMI, cholesterol, sex, and a combination thereof. 10 . The method of claim 1 , wherein the clinical measurements are selected from proteomic measurements, genomic measurements, transcriptome measurements, metabolomics measurements, or a combination thereof. 11 . The method of claim 1 , wherein the cross-validation is selected from k-fold cross-validation, Monte Carlo cross-validation, and Leave N Out validation. 12 . The method of claim 1 , wherein the majority data class is 95% of the class-imbalanced data set and the minority data class is 5% of the class-imbalance data set. 13 . The method of claim 1 , wherein the majority data class is 90% of the class-imbalanced data set and the minority data class is 10% of the class-imbalance data set. 14 . The method of claim 1 , wherein the majority data class is 85% of the class-imbalanced data set and the minority data class is 15% of the class-imbalance data set. 15 . The method of claim 1 , wherein the majority data class is 80% of the class-imbalanced data set and the minority data class is 20% of the class-imbalance data set. 16 . The method of claim 1 , wherein the majority data class is 75% of the class-imbalanced data set and the minority data class is 25% of the class-imbalance data set. 17 . The method of claim 1 , wherein the majority data class is 70% of the class-imbalanced data set and the minority data class is 30% of the class-imbalance data set. 18 . The method of claim 1 , wherein the majority data class is 65% of the class-imbalanced data set and the minority data class is 35% of the class-imbalance data set. 19 . The method of claim 1 , wherein the majority data class is 60% of the class-imbalanced data set and the minority data class is 40% of the class-imbalance data set. 20 - 32 . (canceled)
Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves (measuring movement of the entire body or parts thereof A61B5/11; detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof A61B5/24) · CPC title
for calculating health indices; for individual health risk assessment · CPC title
Evaluating metabolism (using breath test A61B5/083) · CPC title
Identification of persons (methods or arrangements for recognising patterns, e.g. fingerprints, G06F18/00, G06V40/00; identification of persons by analysing their voice or speech G10L17/00) · CPC title
Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.